|[March 14, 2017]
Nashville Start-Up, EvidenceCare, Wraps $2 Million Round of Funding to Fuel Product Acceleration
EvidenceCare, a Nashville-based clinical decision support tool for
healthcare providers, is closing the company's $2 Million Convertible
Note B offering this month, bringing the total raised over the last two
years to more than $3 Million. This round was initially brought about by
existing participants requesting to expand their current investment.
Initiated in early January, it also provided the opportunity for new
investors to become involved in the company's early success. Like the
previous round, this round was capped off with an additional investment
from NueCura Partners, LLC.
"This round of funding is allowing us to accelerate the development of
our enterprise offering, which is built for hospitals," noted
EvidenceCare's COO Jim Jamieson. "As an agile start-up, we are
positioned to respond to market demands," continued Jamieson. "The early
favorable reception from physicians for our product has pushed us to
expedite our investment in integration with EHRs to make EvidenceCare
even more compelling for Enterprise customers." Originally planned for
early 2018, the company will be launching its Enterprise version of
EvidenceCare to hospitals this summer.
EvidenceCare's decision support tool enhances provider workflow and
propels the patient-provider relationship by delivering the latest
medical content in a manner that is quickly and easily consumable by
clinicians at the bedside. The company works with industry leading
experts and medical societies to create content in some of the most
complex and costy conditions in healthcare.
EvidenceCare was conceived in 2014 to solve a fundamental need for
healthcare providers to find and quickly digest the latest treatment
guidelines. The company's patent-pending technology was pioneered by Dr.
Brian Fengler, an emergency room physician, and offers a unique
dashboard interface that presents evidence based on the unique factors
of the specific patient being treated.
"Only 20 percent of US-based healthcare decisions made are
evidence-based, which leads to a third of the more than $3.2 Trillion (News - Alert) in
healthcare expenditures each year being wasted on wrong or inappropriate
care," says Brian Fengler, MD and Chief Executive Officer of
EvidenceCare. "It's time to enhance the patient-provider experience by
giving providers a better tool for treating patients that can improve
patient outcomes and decrease financial impact for hospitals."
In addition to investors who span the healthcare landscape, EvidenceCare
has amassed advisors who shape and influence organizations on a national
and global level. The company's Advisory Board is comprised of
world-renowned economist Dr. Art Laffer, Eric Mueller, who is Chief
Healthcare Strategist for Microsoft (News - Alert), and Mary Mirabelli, Vice President
of Hewlett Packard Enterprise's (HPE) Global Healthcare Practice. The
board's role is to provide insight, vision, and expertise on a macro
level for the organization. NueCura Founder and Managing Partner, Don
Lazas, MD, is a member of EvidenceCare's Board of Directors.
The company is currently entertaining a Series A equity round of funding
targeted for this summer. That round will allow the organization to turn
their focus exclusively to rapidly expanding content and the anticipated
growth related to the addition of the Enterprise product offering.
Nashville-based EvidenceCare is a clinical decision support platform
designed by practicing emergency physician, Dr. Brian Fengler. Unlike
any tool on the market, EvidenceCare provides clinicians with access
patient specific evidence-based treatment recommendations at the bedside
in as little as 30 seconds. Since its launch in July 2016, the company's
proprietary content publishing platform is delivering protocols authored
by industry-leading experts to nearly 1800 providers worldwide.
To learn more visit www.evidence.care.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170314006291/en/
[ InfoTech Spotlight's Homepage ]